Biotech Bloodbath: Hedge Fund Hotel Sarepta Collapses After Study Disappoints
Not every stocks grows to the sky like Tesla (which just hit $835 after hours)… In 2016, Sarepta Therapeutics suffered a catastrophic 50%-plus plunge after the FDA voted that SRPT’s muscular dystrophy drug was not effective… What happened next? Well it exploded higher of course… And now, in 2021, the hedge-fund-hotel has done it again,…